Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Best PR guys
View:
Comment by SPCEO1 on May 31, 2021 11:44am
By this point, we must have several patients in the MTD portion of the study. I find it quite odd that Paul indicated he is not aware of what is going on in an open-label study. Would Gettysburg and other clinics refuse to report info back for a period of time? Would there be some internal procedure to block the CEO from learning the status until a certain amount of data was collected? Is this ...more  
Comment by qwerty22 on May 31, 2021 1:21pm
It has to be deflection, I think they want to release info on their terms and so he just closed that discussion down. I find it unimaginable that Paul isn't asking Christain how the trial is going every day of the week and twice on Sundays.
Comment by qwerty22 on May 31, 2021 1:33pm
I think the cancer study is just too early to be generating much data either way. Doses are likely to be too low to be impacting safety or efficacy, although we might now be reaching dose levels that matter. Then again something interesting might have occurred in the low doses, who knows? The Facebook post is from the clinical co-ordinator at Gettysburg. Would he be publically gushing about a ...more  
Comment by palinc2000 on May 31, 2021 4:16pm
I ead burnt once by relying on very promising anecdotal results !!! It is my experience that unless the results are statisticallly significant they dont mean anything....
Comment by scarlet1967 on May 31, 2021 12:14pm
Reading between the lines it's a great news that additional sites will be opening this month so one could anticipate so far the trial hasn't had major issues.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse